Claim Missing Document
Check
Articles

Found 6 Documents
Search
Journal : Prosiding University Research Colloquium

Selain Terapi Antiretroviral Secara Terkontrol, Pasien HIV Juga Memerlukan Dukungan Psikologis dan Lingkungan Santoso, Setiyo Budi; Lutfiyati, Heni; Afifi, Ulfahishofi Hanifah; Ratnafuri, Shellyta
Prosiding University Research Colloquium Proceeding of The 13th University Research Colloquium 2021: Kesehatan dan MIPA
Publisher : Konsorsium Lembaga Penelitian dan Pengabdian kepada Masyarakat Perguruan Tinggi Muhammadiyah 'Aisyiyah (PTMA) Koordinator Wilayah Jawa Tengah - DIY

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Artikel ini menyajikan profil kualitas hidup pasien HIV yang telah menjalani terapi secara terkontrol. Secara spesifik, peneliti mengulas kebutuhan khusus subyek penelitian terhadap dukungan psikologis dan lingkungan. Penelitian berlangsung di Rumah Sakit Umum Daerah KRT Setjonegoro Wonosobo dengan melibatkan 68 subyek penelitian. Seluruh subyek penelitian merupakan pasien HIV yang sedang menjalani terapi antiretroviral (rawat jalan) secara terkontrol dengan durasi lebih dari 6 bulan, dan berusia lebih dari 15 tahun. Investigasi profil kualitas hidup menggunakan kuesioner WHOQOL-HIV Bref versi Bahasa Indonesia. Hasil penelitian menunjukkan bahwa pasien HIV yang menjalani terapi secara terkontrol memiliki nilai kualitas hidup yang lebih baik dari pasien HIV umum. Terapi antiretroviral telah membantu mereka memiliki kualitas fisik, tingkat kemandirian, sisi spiritual dan kemampuan sosial dalam menjalani hidup. Meski begitu, mereka memerlukan intervensi psikologis dan dukungan lingkungan agar memiliki kualitas diri yang merata. Tenaga kesehatan yang terlibat dalam pengelolaan pasien HIV, perlu memberikan intervensi profesional untuk meningkatkan kemampuan mereka dalam berkonsentrasi, serta memastikan mereka senantiasa nyaman dengan kondisi fisiknya. Lebih dari itu, perlu gotong royong pula oleh relasi (keluarga, teman, komunitas) dan tenaga kesehatan dalam menjamin pasien HIV tidak mengalami kesulitan finansial, mampu menikmati waktu secara rileks, dan merasa aman sebagai bagian dari lingkungan sebagaimana masyarakat secara umum.
Website-based Scientific Traditional Medicine Information Prototype Salamah, Nurul Umi; Majid, Nur Reviana; Makarim, Ahmad Faiz; Pribadi, Prasojo; Santoso, Setiyo Budi
Prosiding University Research Colloquium Proceeding of The 15th University Research Colloquium 2022: Bidang MIPA dan Kesehatan
Publisher : Konsorsium Lembaga Penelitian dan Pengabdian kepada Masyarakat Perguruan Tinggi Muhammadiyah 'Aisyiyah (PTMA) Koordinator Wilayah Jawa Tengah - DIY

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

The article presents a website-based design for traditional medicine information that can be traced to its truth value based on scientific literature. The author arranges the application workflow using draw.io online diagram software. Preparation of interface design recommendations using the Microsoft Power Point application. The flow of the process of searching for traditional medicine information data begins when the user presses the start button, then the main menu will appear, then search or view data on various traditional medicines. traditional medicines, benefits, method of use and dosage.
Telegram-Bot Applications in Drug Information Services and Pharmaceutical Counseling Anggitha, Shelvia Lharas; Rahayu, Ngesti; Pribadi, Prasojo; Santoso, Setiyo Budi
Prosiding University Research Colloquium Proceeding of The 15th University Research Colloquium 2022: Mahasiswa (Student Paper Presentation) B
Publisher : Konsorsium Lembaga Penelitian dan Pengabdian kepada Masyarakat Perguruan Tinggi Muhammadiyah 'Aisyiyah (PTMA) Koordinator Wilayah Jawa Tengah - DIY

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

This article presents the development of a bot application to assist patients in obtaining drug information and counseling services from pharmacists. The draw.io network software was used to build a bot workflow. This study's findings include recommendations for bot workflows as well as examples of user interface designs.
Online Home Pharmacy Care Prototype Savita, Putri Diana; Miftahuda, Dwiky; Safi'a, Winda Alawiyah; Pribadi, Prasojo; Santoso, Setiyo Budi
Prosiding University Research Colloquium Proceeding of The 15th University Research Colloquium 2022: Mahasiswa (Student Paper Presentation) B
Publisher : Konsorsium Lembaga Penelitian dan Pengabdian kepada Masyarakat Perguruan Tinggi Muhammadiyah 'Aisyiyah (PTMA) Koordinator Wilayah Jawa Tengah - DIY

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

This article presents the design of an online pharmacy service application at home. Development of application workflows using software in the draw.io network. The development includes a consultation menu, ordering medication/prescription redemption, camera features to take pictures (prescriptions), payments, and delivery messages.
Exploring the Role of Overall Survival in Chemotherapy Protocol: A Literatur Review: Telaah Pustaka Penilaian Overall Survival Sebagai Parameter Klinis Tata Terapi Kanker Pratiwi, Selma Septi; Khamdun, Ibnu; Fitrianasari, Resma Dwi Putri; Vaira, Tischa; Riska, R; Santoso, Setiyo Budi
Prosiding University Research Colloquium Proceeding of The 18th University Research Colloquium 2023: Bidang MIPA dan Kesehatan
Publisher : Konsorsium Lembaga Penelitian dan Pengabdian kepada Masyarakat Perguruan Tinggi Muhammadiyah 'Aisyiyah (PTMA) Koordinator Wilayah Jawa Tengah - DIY

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Overall survival (OS) assesses the patient's survival rate after undergoing therapy. The evaluation of OS becomes a reliable clinical endpoint for assessing the malignancy response to chemotherapy intervention. Here in, we review a number of publications on PCR data in various chemotherapy protocols for different types of cancer. The literature review involves nine scientific articles that meet the inclusion criteria provided by the PubMed database. Our findings present the performance of chemotherapy protocols with the highest OS values for each type of cancer, including: Non-Small Cell Lung Cancer Metastasis (Durvalumab plus Tremelimumab-31.2), Non-Metastatic Non-Small Cell Lung Cancer (Nivolumab-30.8), Small Cell Lung Cancer (Carboplatin and Etoposide-13.2), Breast Cancer (Ribociclib plus Fulvestrant-67.6), Metastatic Breast Cancer (Olaparib-18.9), Metastatic Colorectal Cancer (Trifluridine/tipiracil-13.1), Liver Cancer (SBRT 44.1). This article reviews a number of publications on PCR data in various chemotherapy protocols for different types of cancer.
Exploring the Role of Progression Free Survival in Chemotherapy Protocol: A Literatur Review: Telaah Pustaka Penilaian Progression Free Survival Sebagai Parameter Klinis Tata Terapi Kanker Padirja, Shyfa Anindya; Rahayu, Ngesti; Fitria, Tisa; Fasya, Saniya Puspa; Umma, Nafa; Zahrah, Salsabila Salma; Santoso, Setiyo Budi
Prosiding University Research Colloquium Proceeding of The 18th University Research Colloquium 2023: Bidang MIPA dan Kesehatan
Publisher : Konsorsium Lembaga Penelitian dan Pengabdian kepada Masyarakat Perguruan Tinggi Muhammadiyah 'Aisyiyah (PTMA) Koordinator Wilayah Jawa Tengah - DIY

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Progression-Free Survival (PFS) measures cancer patients' resistance to tumor progression. This alternative measurement is effective in assessing the performance of cancer therapy protocols and may serve an evidence for evaluating the quality of life of patients and planning follow-up treatments. Here in, we review a number of PFS data publications for drugs used in cancer therapy. The review involves ten scientific articles met the inclusion criteria provided by the PubMed database. Our finding present the optimal performance of chemotherapy protocols in preventing disease progression in seven various cancer populations. The highest PFS values for each cancer such as: crizotinib for lung cancer (28.71 months), enzalutamide for prostate cancer (7.1 months), pamiparib for stomach cancer (3.7 months), anlotinib for liver cancer (4.2 months), irinotecan plus raltitrexed for esophageal cancer (3.91 months), folfoxiri plus bevacizumab for metastatic colorectal cancer (10.7 months), and paclitaxel plus vistusertib for ovarian carcinoma (4.5 months).